Richard C Mulligan1, Sean D Kristjansson2, Angela M Reiersen3, Andres S Parra3, Andrey P Anokhin3. 1. Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: mulligar@psychiatry.wustl.edu. 2. Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; Pason Systems Corporation, Calgary, Alberta, Canada. 3. Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Abstract
BACKGROUND: The dopamine D4 receptor gene (DRD4) has been implicated in psychiatric disorders in which deficits of self-regulation are a prominent feature (e.g., attention-deficit hyperactivity disorder and substance use disorders) and in dopamine D4 receptor insensitivity within prefrontal regions of the brain. Our hypothesis was that carriers of 7-repeats in the Variable Number of Tandem Repeats (VNTR) of DRD4 (7R+) would recruit prefrontal brain regions involved in successful inhibitory control to a lesser degree than non-carriers (7R-) and demonstrate less inhibitory control as confirmed by observation of locally reduced blood oxygenation level dependent (BOLD) % signal change and lower accuracy while performing "No-Go" trials of a Go/No-Go task. METHODS: Participants (age=18, n=62, 33 females) were recruited from the general population of the St. Louis, Missouri region. Participants provided a blood or saliva sample for genotyping, completed drug and alcohol-related questionnaires and IQ testing, and performed a Go/No-Go task inside of a 3T fMRI scanner. RESULTS: Go/No-Go task performance did not significantly differ between 7R+ and 7R- groups. Contrast of brain activity during correct "No-Go" trials with a non-target letter baseline revealed significant BOLD activation in a network of brain regions previously implicated in inhibitory control including bilateral dorsolateral prefrontal, inferior frontal, middle frontal, medial prefrontal, subcortical, parietal/temporal, and occipital/cerebellar brain regions. Mean BOLD % signal change during "No-Go" trials was significantly modulated by DRD4 genotype, with 7R+ showing a lower hemodynamic response than 7R- in right anterior prefrontal cortex/inferior frontal gyrus, left premotor cortex, and right occipital/cerebellar areas. Follow-up analyses suggested that 7-repeat status accounted for approximately 5-6% of the variance in the BOLD response during "No-Go" trials. DISCUSSION: The DRD4 7-repeat allele may alter dopaminergic function in brain regions involved in inhibitory control. When individuals must inhibit a prepotent motor response, presence of this allele may account for 5-6% of the variance in BOLD signal in brain regions critically associated with inhibitory control, but its influence may be associated with a greater effect on brain than on behavior in 18-year-olds from the general population.
BACKGROUND: The dopamine D4 receptor gene (DRD4) has been implicated in psychiatric disorders in which deficits of self-regulation are a prominent feature (e.g., attention-deficit hyperactivity disorder and substance use disorders) and in dopamine D4 receptor insensitivity within prefrontal regions of the brain. Our hypothesis was that carriers of 7-repeats in the Variable Number of Tandem Repeats (VNTR) of DRD4 (7R+) would recruit prefrontal brain regions involved in successful inhibitory control to a lesser degree than non-carriers (7R-) and demonstrate less inhibitory control as confirmed by observation of locally reduced blood oxygenation level dependent (BOLD) % signal change and lower accuracy while performing "No-Go" trials of a Go/No-Go task. METHODS:Participants (age=18, n=62, 33 females) were recruited from the general population of the St. Louis, Missouri region. Participants provided a blood or saliva sample for genotyping, completed drug and alcohol-related questionnaires and IQ testing, and performed a Go/No-Go task inside of a 3T fMRI scanner. RESULTS: Go/No-Go task performance did not significantly differ between 7R+ and 7R- groups. Contrast of brain activity during correct "No-Go" trials with a non-target letter baseline revealed significant BOLD activation in a network of brain regions previously implicated in inhibitory control including bilateral dorsolateral prefrontal, inferior frontal, middle frontal, medial prefrontal, subcortical, parietal/temporal, and occipital/cerebellar brain regions. Mean BOLD % signal change during "No-Go" trials was significantly modulated by DRD4 genotype, with 7R+ showing a lower hemodynamic response than 7R- in right anterior prefrontal cortex/inferior frontal gyrus, left premotor cortex, and right occipital/cerebellar areas. Follow-up analyses suggested that 7-repeat status accounted for approximately 5-6% of the variance in the BOLD response during "No-Go" trials. DISCUSSION: The DRD4 7-repeat allele may alter dopaminergic function in brain regions involved in inhibitory control. When individuals must inhibit a prepotent motor response, presence of this allele may account for 5-6% of the variance in BOLD signal in brain regions critically associated with inhibitory control, but its influence may be associated with a greater effect on brain than on behavior in 18-year-olds from the general population.
Authors: Stewart H Mostofsky; Joanna G B Schafer; Michael T Abrams; Melissa C Goldberg; Abigail A Flower; Avery Boyce; Susan M Courtney; Vince D Calhoun; Michael A Kraut; Martha B Denckla; James J Pekar Journal: Brain Res Cogn Brain Res Date: 2003-07
Authors: A M Clare Kelly; Robert Hester; Kevin Murphy; Daniel C Javitt; John J Foxe; Hugh Garavan Journal: Eur J Neurosci Date: 2004-06 Impact factor: 3.386
Authors: Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling Journal: J Neurosci Date: 2006-10-04 Impact factor: 6.167
Authors: Sebastian Heinzel; Thomas Dresler; Christina G Baehne; Monika Heine; Andrea Boreatti-Hümmer; Christian P Jacob; Tobias J Renner; Andreas Reif; Klaus-Peter Lesch; Andreas J Fallgatter; Ann-Christine Ehlis Journal: Cereb Cortex Date: 2012-05-22 Impact factor: 5.357
Authors: Jennifer S Richards; Alejandro Arias Vásquez; Daan van Rooij; Dennis van der Meer; Barbara Franke; Pieter J Hoekstra; Dirk J Heslenfeld; Jaap Oosterlaan; Stephen V Faraone; Catharina A Hartman; Jan K Buitelaar Journal: World J Biol Psychiatry Date: 2016-05-12 Impact factor: 4.132
Authors: Dennis van der Meer; Catharina A Hartman; Daan van Rooij; Barbara Franke; Dirk J Heslenfeld; Jaap Oosterlaan; Stephen V Faraone; Jan K Buitelaar; Pieter J Hoekstra Journal: J Psychiatry Neurosci Date: 2017-03 Impact factor: 6.186
Authors: Nelleke C van Wouwe; Kristen E Kanoff; Daniel O Claassen; Charis A Spears; Joseph Neimat; Wery P M van den Wildenberg; Scott A Wylie Journal: J Cogn Neurosci Date: 2016-02-02 Impact factor: 3.225
Authors: Stefanie M Beck; Hannes Ruge; Christoph Schindler; Martin Burkart; Robert Miller; Clemens Kirschbaum; Thomas Goschke Journal: Hum Psychopharmacol Date: 2016-05 Impact factor: 1.672